MCRB SERES THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of CFO Seres Therapeutics appointed Marella Thorell as Executive Vice President and Chief Financial Officer, succeeding David Arkowitz, effective March 25, 2024.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC